Skip to main content

MARSHALL WACE, LLP

Position in NTRA — Natera, Inc.

CIK 1318757 LONDON, X0

Position in NTRA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$35,739,920
+$25,000,058 QoQ
Shares Held
131,663
+145.2% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#114
of 844 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NTRA Over Time

Shares Held

Position Value (USD)

Derivatives in NTRA

reported options exposure · as of Jun 30, 2026
CallValue
$27,145
CallShares
100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $872,920,182 across 27 Diagnostics & Research names. NTRA ranks #8 (4.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NTRA
Natera, Inc.
This page
131,663 $35,739,920

All Filings in NTRA

Export CSV
29 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $27,145 100
2026-06-30 $35,739,920 131,663
2026-03-31 $159,992 800
2026-03-31 $179,991 900
2026-03-31 $10,739,862 53,702
2025-12-31 $183,272 800
2025-12-31 $114,545 500
2025-09-30 $772,656 4,800
2025-09-30 $1,706,282 10,600
2025-03-31 $37,408,883 264,542
2024-12-31 $13,487,160 85,200
2024-12-31 $68,771,218 434,436
2024-09-30 $57,260,288 451,046
2024-06-30 $103,783,293 958,383
2024-03-31 $57,048,449 623,753
2023-12-31 $27,367,478 436,901
2023-09-30 $36,026,136 814,150
2023-06-30 $68,664,466 1,411,107
2023-03-31 $73,716,957 1,327,755
2022-12-31 $59,938,660 1,492,125
2022-09-30 $53,862,886 1,229,185
2022-06-30 $44,577,352 1,257,826
2022-03-31 $57,420,063 1,411,506
2021-12-31 $169,588,674 1,815,919
2021-09-30 $151,531,765 1,359,761
2021-06-30 $143,972,388 1,268,144
2021-03-31 $119,209,280 1,174,013
2020-12-31 $90,687,998 911,254
2020-03-31 $1,322,290 44,283